Status:
COMPLETED
A Study to Evaluate the Effect of Vitamin D Supplementation on Insulin Sensitivity and Secretion
Lead Sponsor:
Sitaram Bhartia Institute of Science and Research
Conditions:
Diabetes Mellitus, Non-Insulin-Dependent
Eligibility:
MALE
30+ years
Phase:
NA
Brief Summary
The purpose of the study is to evaluate the change in insulin sensitivity and secretion indices (early markers for development of diabetes) after 4 weeks of a megadose of Vitamin D. This will also hel...
Detailed Description
Accumulating evidence suggests that serum Vitamin D levels may be inversely related to the prevalence of diabetes, to the concentration of glucose , insulin resistance and metabolic syndrome.The avail...
Eligibility Criteria
Inclusion
- Male
- ≥30 years of age
- Waist circumference ≥80 cm
Exclusion
- Diabetic- Fasting Blood Sugar \>126 mg/dl or on anti-diabetic medication
- BP\>140/90 or on anti-hypertensive medication
- Receiving Vitamin D or calcium supplementation
- Chronic disease-renal/hepatic/malignancy/gastrointestinal
- On any medication within the last one month which could potentially influence insulin secretion, insulin sensitivity, Vitamin D or Calcium metabolism
- Febrile illness or infective morbidity in the past 10 days
Key Trial Info
Start Date :
April 1 2006
Trial Type :
INTERVENTIONAL
End Date :
May 1 2006
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT00320853
Start Date
April 1 2006
End Date
May 1 2006
Last Update
May 3 2006
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Sitaram Bhartia Institute of Science and Research
New Delhi, National Capital Territory of Delhi, India, 110016